Literature DB >> 23288019

Low-grade astrocytoma: surgical outcomes in eloquent versus non-eloquent brain areas.

André de Macedo Bianco1, Flavio Key Miura, Carlos Clara, Jose Reynaldo W Almeida, Clemar Correa da Silva, Manoel Jacobsen Teixeira, Suely K Nagahashi Marie.   

Abstract

A retrospective study of 81 patients with low-grade astrocytoma (LGA) comparing the efficacy of aggressive versus less aggressive surgery in eloquent and non-eloquent brain areas was conducted. Extent of surgical resection was analyzed to assess overall survival (OS) and progression- free survival (PFS). Degree of tumor resection was classified as gross total resection (GTR), subtotal resection (STR) or biopsy. GTR, STR and biopsy in patients with tumors in non-eloquent areas were performed in 31, 48 and 21% subjects, whereas in patients with tumors in eloquent areas resections were 22.5, 35 and 42.5%. Overall survival was 4.7 and 1.9 years in patients with tumors in non-eloquent brain areas submitted to GTR/STR and biopsy (p=0.013), whereas overall survival among patients with tumors in eloquent area was 4.5 and 2.1 years (p=0.33). Improved outcome for adult patients with LGA is predicted by more aggressive surgery in both eloquent and non-eloquent brain areas.

Entities:  

Mesh:

Year:  2013        PMID: 23288019     DOI: 10.1590/s0004-282x2012005000017

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  4 in total

1.  Clinical experience of glioma surgery using "tailed bullet": overcoming the limitations of conventional neuro-navigation guided surgery.

Authors:  Jin Mo Cho; Jae Joon Lim; Se-Hyuk Kim; Kyung Gi Cho
Journal:  Yonsei Med J       Date:  2015-03       Impact factor: 2.759

2.  ASYMMETRIC CELL DIVISION: IMPLICATIONS FOR GLIOMA DEVELOPMENT AND TREATMENT.

Authors:  Kate Marie Lewis; Claudia Petritsch
Journal:  Transl Neurosci       Date:  2013-12       Impact factor: 1.757

3.  Quantitative proteomic analysis shows differentially expressed HSPB1 in glioblastoma as a discriminating short from long survival factor and NOVA1 as a differentiation factor between low-grade astrocytoma and oligodendroglioma.

Authors:  Marcela Gimenez; Suely Kazue Nagahashi Marie; Sueli Oba-Shinjo; Miyuki Uno; Clarice Izumi; João Bosco Oliveira; Jose Cesar Rosa
Journal:  BMC Cancer       Date:  2015-06-25       Impact factor: 4.430

4.  Clinical application of 3.0 T intraoperative magnetic resonance combined with multimodal neuronavigation in resection of cerebral eloquent area glioma.

Authors:  Chang-Yu Lu; Xiao-Lin Chen; Xiao-Lei Chen; Xiao-Jing Fang; Yuan-Li Zhao
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.